View source for TCT 2009 schedule

Here is the page we will use to coordinate the TV events at TCT 2009. The filming will take place in Room East 264 at the Moscone Convention Center.

----
__NOTOC__

==Click on Date for Detailed Schedule==

[[{{PAGENAME}}#Tuesday September 22, 2009|Tuesday September 22, 2009]]

[[{{PAGENAME}}#Wednesday September 23, 2009|Wednesday September 23, 2009]]

[[{{PAGENAME}}#Thursday September 24, 2009|Thursday September 24, 2009]]

[[{{PAGENAME}}#Friday September 25, 2009|Friday September 25, 2009]]

----


==Tuesday September 22, 2009==

===12:30 PM===
''12:30 PM - 1:00 PM''
*'''Interviewee:''' Peter Smits
*'''Trial:''' COMPARE. A Prospective, Randomized Trial of Everolimus-eluting vs. Paclitaxel-Eluting Stents
*'''Embargo lift:''' Wednesday 9/23 12:30 PM

===1:00 PM===
''1:00 PM - 1:30 PM''
*'''Interviewee:''' Shamir Mehta
*'''Trial: ''' CURRENT-PCI OASIS 7. A Prospective, Randomized, Placebo-Controlled Trial of High- vs. Standard-Dose Clopidogrel and High- vs. Low-Dose Aspirin in Patients Undergoing PCI for ACS  
*'''Embargo lift:''' Thursday 9/24 12:30 PM  

===2:00 PM===
''2:00 PM - 2:30 PM''
*'''Interviewee:''' John Spertus
*'''Trial: ''' NEVO RES-ELUTION I QOL: Formal Quality-of-Life Assessment from a Prospective Trial of a Novel Sirolimus-Eluting Stent and a Paclitaxel-Eluting Stent
*'''Embargo lift:''' Thursday 9/24 3:00 PM 

===2:30 PM===
''2:30 PM - 3:00 PM''
*'''Interviewee:''' Eberhard Grube
*'''Trial: ''' BIOFREEDOM: A Prospective Randomized Trial of a Polymer-Free Biolimus A9-Eluting Stent
*'''Embargo lift:''' Thursday 9/24 3:30 PM 

===3:00 PM===
''3:00 PM - 3:30 PM''
*'''Interviewee:''' David Allie
*'''Trial: ''' CROSS-CLI: A Prospective Multicenter Registry of Ultrasound-Facilitated Recanalization of Peripheral Chronic Total Occlusions
*'''Embargo lift:''' Thursday 9/24 5:10 PM

===3:30 PM===
''3:30 PM - 4:00 PM''
*'''Interviewee:''' Douglas Losordo
*'''Trial: ''' ACT34-CMI: One-Year Results from a Prospective, Randomized, Placebo-Controlled Phase II Trial of CD34+ Cells in Patients with Refractory Angina 
*'''Embargo lift:''' Thursday 9/24 5:40 PM

===4:00 PM===
''4:00 PM - 4:30 PM''
*'''Interviewee:''' Gary Ansel
*'''Trial: ''' ARMOUR: A Prospective, Nonrandomized Study of the Mo.Ma Proximal Cerebral Protection Device in High Surgical Risk Subjects Undergoing Carotid Artery Stenting 
*'''Embargo lift:''' Thursday 9/24 5:25 PM



===5:00 PM===
''5:00 PM - 5:30 PM''
*'''Interviewee:'''  Francesco  Prati
*'''Trial:''' COCKTAIL: A Prospective Randomized Trial of Intracoronary Abciximab Infusion in Patients with Thrombotic Lesions Assessed by OCT   
*'''Embargo lift:''' Thursday 9/24 4:05 PM


''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''

== Wednesday September 23, 2009==

===8:30 AM===
''8:30 AM - 9:00 AM''
*'''Interviewee:''' William Fearon
*'''Trial: ''' FAME: 2-Year Follow-up From a Prospective, Randomized Trial of FFR-Guided vs. Angiography-Guided PCI in Patients with Multivessel Coronary Artery Disease 

===9:00 AM===
''9:00 AM - 9:30 AM''
*'''Interviewee:''' Josef Veselka 
*'''Trial: ''' STATINS PRE-PCI: A Prospective Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina   

===9:30 AM===
''9:30 AM - 10:00 AM''
*'''Interviewee:''' Volker Klauss
*'''Trial: ''' LEADERS. 2-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Bioabsorbable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer

===10:00 AM===
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Deepak Bhatt
*'''Trial: ''' 1) COGENT. A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel 
2) CHARISMA GENOMICS SUBSTUDY. Evaluation of the CYP2C19 Polymorphism in a Prospective, Randomized, Placebo-Controlled Trial of Chronic Clopidogrel Use for Primary and Secondary Prevention

===10:15 AM===
''10:15 AM - 10:30 AM''
*'''Interviewee:''' Douglas Losordo 
*'''Trial: ''' ACT 34-CMI

===10:30 AM===
''10:30 AM - 11:00 AM''
*'''Interviewee:''' David Cohen
*'''Trial: ''' TRITON-TIMI 38 ECONOMIC SUBSTUDY. Cost-Effectiveness of Prasugrel vs. Clopidogrel From a Prospective, Randomized Trial of Patients with ACS Undergoing PCI   

===11:00 AM===
''11:00 AM - 11:30 AM''
*'''Interviewee:''' Michelle O'Donoghue
*'''Trial: ''' The Risk of CV Events for Patients Treated with Clopidogrel or Prasugrel in
Combination with a Proton Pump Inhibitor: Results from the TRITON-TIMI 38 Trial

===12:00 PM===
''12:00 PM - 12:30 PM''
*'''Interviewee:''' Robert Byrne
*'''Trial: ''' ISAR-DESIRE 2. A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents for Treatment of Restenosis in Sirolimus-Eluting Stents    

===1:00 PM===
''1:00 PM - 1:30 PM''
*'''Interviewee:''' Sunil Rao
*'''Trial: ''' Radial Artery Procedures (not a trial) 

===1:30 PM===
''1:30 PM - 2:00 PM''
*'''Interviewee:''' Stephan Windecker
*'''Trial: ''' SIRTAX-LATE.  5-Year Clinical and Randomized Trial of Sirolimus-Eluting and Paclitaxel-Eluting Stents

===3:45 PM===
''3:45 PM - 4:00 PM''
*'''Interviewee:''' Christopher Cannon
*'''Trial: ''' PLATO INVASIVE.  A Prospective, Randomized, Placebo-Controlled Trial of Ticagrelor vs. Clopidogrel in Patients with ACS Managed with an Invasive Strategy

''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''

== Thursday September 24, 2009==

===12:45 PM===
''12:45 PM - 1:15 PM''
*'''Interviewee:''' Cheol Whan Lee
*'''Trial: ''' 1) ZEST: Final Angiographic and IVUS Results From a Large-Scale Randomized Trial of Zotarolimus-Eluting, Sirolimus-Eluting and Paclitaxel-Eluting Stents; 2) CILOTAX: A Prospective, Randomized, Controlled Trial of a Stent Eluting Cilostazol and Paclitaxel   

===1:15 PM===
''1:15 PM - 1:45 PM''
*'''Interviewee:''' Flavio Ribichini  
*'''Trial: ''' CEREA-DES: A Prospective Randomized Trial of Corticosteroids in Patients Undergoing Stent Implantation    

===2:15 PM===
''2:15 PM - 2:45 PM''
*'''Interviewee:''' Patrick Ohlmann
*'''Trial: ''' MISTRAL: A Prospective Randomized Trial of Ambulance-Initiated vs. Cath Lab-Initiated Intravenous Abciximab in Patients with STEMI    

===2:45 PM===
''2:45 PM - 3:15 PM''
*'''Interviewee:''' Junbo Ge
*'''Trial: ''' NO REFLOW: A Prospective Randomized Trial of Intracoronary vs. Guide Catheter Infusion of Nitrates vs. Calcium Channel Blockers in Patients with No Reflow After Primary PCI in STEMI    

===3:15 PM===
''3:15 PM - 3:45 PM''
*'''Interviewee:''' Giulio Guagliumi
*'''Trial: ''' OCTAMI: A Prospective Randomized Trial of Zotarolimus-Eluting and Bare-Metal Stents in STEMI Assessed by OCT    

===3:45 PM===
''3:45 PM - 4:15 PM''
*'''Interviewee:''' Josep Rodes-Cabau
*'''Trial: ''' The Canadian Transcatheter Aortic Valve Implantation Program: Acute and Late Follow-up from a Multicenter Consecutive Series of Patients with Inoperable or High-Surgical Risk Aortic Stenosis    

===6:00 PM===
''6:00 PM - 6:30 PM''
*'''Interviewee:''' John Spertus
*'''Trial: ''' NEVO RES-ELUTION 


''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''

== Friday September 25, 2009==

===10:30 AM===
''10:30 AM - 11:00 AM''
*'''Interviewee:''' Simon Redwood
*'''Trial: ''' BCIS-1. A Prospective, Randomized Trial of Intraaortic Balloon Pump Counterpulsation in High-Risk Patients Undergoing PCI

===11:00 AM===
''11:00 AM - 11:30 AM''
*'''Interviewee:''' Arnold Seto
*'''Trial: ''' FAUST. A Prospective, Randomized Trial of Ultrasound-Guided vs. Standard Femoral Arterial Access

===11:30 AM===
''11:30 AM - 12:00 PM''
*'''Interviewee:''' Dirk Walter
*'''Trial: ''' PROVASA: A Prospective, Randomized, Placebo-Controlled Trial of Intra-Arterial Progenitor Cell Transplantation of Bone Marrow Mononuclear Cells in Patients with Peripheral Arterial Occlusive Disease   

===12:30 PM===
''12:30 PM - 1:00 PM''
*'''Interviewee:''' Rolf Michels
*'''Trial: ''' DEBATER. A Prospective, Randomized Trial of Drug-Eluting vs. Bare Metal Stents With or Without Abciximab in STEMI

===1:00 PM===
''1:00 PM - 1:30 PM''
*'''Interviewee:''' Gregg Stone
*'''Trial: ''' 1) SPIRIT IV. A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents
2) PROSPECT. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque, 3) HORIZONS-AMI. 2-Year Follow-up From a Prospective, Randomized Trial of Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare Metal Stents in STEMI

===1:30 PM===
''1:30 PM - 2:00 PM''
*'''Interviewee:''' Henry Krum
*'''Trial: ''' SYMPLICITY I. 1-Year Results Following Sympathetic Renal Denervation in Refractory Hypertension


''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''